takeda pharmaceutical co ltd
(4502:Tokyo Stock Exchange)
Stephen W. Kaldor Ph.D.
|Age||Total Calculated Compensation||This person is connected to 19 board members in 3 different organizations across 10 different industries.|
See Board Relationships
Mr. Stephen W. Kaldor, also known as Steve, PhD, serves as Acting Chief Executive Officer Quanticel Pharmaceuticals, Inc. Mr. Kaldor serves as an Advisor at Thomas, McNerney & Partners and advises on drug discovery. He served as an Advisor of Achaogen, Inc. He is an Associate Editor of the Journal of Combinatorial Chemistry (ACS). He was a Venture Partner at Versant Ventures Inc. He gained over 12 years of research and development, drug discovery and development experience ...
12-10, Nihonbashi 2-chomePhone: 81 3 3278 2111
Osaka, -- 103-8668
Fax: 81 3 3278 2000
Board Members Memberships*
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
|There is no Competitor Compensation data available.|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.